GlassScriptPhysician profile
Jolee Preston
NPI 1639456791
$1,083.89
in general payments reported to CMS, 2019-2025
13 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $46.31 · 2023: $253 · 2024: $265 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $754.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $394.45 | 2021-2025 | Reblozyl |
| Rigel Pharmaceuticals, INC. | $211.32 | 2023-2024 | Tavalisse, Rezlidhia |
| Dova Pharmaceuticals | $101.29 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $95.77 | 2023 | Imbruvica |
| Puma Biotechnology, INC. | $80.59 | 2021-2024 | |
| Pfizer INC. | $38.17 | 2022-2024 | |
| Astellas Pharma US INC | $34.31 | 2025 | Vyloy |
| Celgene Corporation | $30.43 | 2024-2025 | Reblozyl |
| Beone Medicines USA, INC. | $27.19 | 2025 | Brukinsa |
| Daiichi Sankyo INC. | $22.33 | 2025 | Datroway |
| Abbvie INC. | $19.54 | 2023 | |
| Lilly USA, LLC | $14.35 | 2023 | Verzenio, Jaypirca, Retevmo |
| Geron Corporation | $14.15 | 2025 | Rytelo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jolee Preston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.